Skip to main content
OpenTrials

Clinical trial condition

Recurrent Paranasal Sinus Squamous Cell Carcinoma

Explore clinical trials studying Recurrent Paranasal Sinus Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

5 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Paranasal Sinus Squamous Cell Carcinoma trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

NCT07156227

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
Locations
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View Trial Details
Active, not recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

NCT04576091

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +52 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
View Trial Details

Related conditions